Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

UK CLL Long-term Follow-up Study

Trial Profile

UK CLL Long-term Follow-up Study

Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2018

At a glance

  • Drugs Obinutuzumab (Primary) ; Ofatumumab (Primary) ; Alemtuzumab; Bendamustine; Cyclophosphamide; Cyclophosphamide; Fludarabine; Fludarabine; Mitoxantrone; Rituximab
  • Indications Chronic lymphocytic leukaemia
  • Focus Therapeutic Use
  • Acronyms UK CLL LTFU
  • Most Recent Events

    • 13 Jun 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top